Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bexsero Immunisation for Gonorrhoea Cross-Reactivity
NCT04297436Completed
- Sponsor
- University of Oxford
- Start
- May 2021
- Primary completion
- Feb 2022
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Open-label, single-arm trial of meningococcal group B vaccine in gonorrhea, sponsored by University of Oxford. Primary endpoint: Humoral and T cell cross-reactive responses against Neisseria gonorrhoeae. Started May 2021; status: completed.
02
Drugs
meningococcal group B vaccine
03
Conditions
gonorrhea
Beyond the preview
Go deeper on NCT04297436.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04297436.